prices of glp 1 drugs Costly GLP-1 are Rarely Covered for Weight Loss by Marketplace Plans What is the 'real' cost
Description
Storage and handling matter with compounded medications
77 A meta-analysis of 76 RCTs, involving over 100,000 adults with overweight, obesity, or type 2 diabetes found that GLP-1 RA treatment, compared to placebo or other active comparators, was associated with a modestly elevated risk of cholelithiasis (RR: 1.27, 95% CI 1.10, 1.47), cholecystitis (RR: 1.36, 95% CI 1.14, 1.62), and overall biliary disease (RR: 1.55, 95% CI 1.08, 2.22), corresponding to an absolute increase of approximately 27 events per 10,000 patients per year
GLP-1R agonist 2 has the potential for research in metabolic diseases such as type 2 diabetes and obesity [1]
Caution when using GLP-1 RAs in older patients, especially those 75 years old, has been suggested to prevent the risk of sarcopenia
Coskun, T
Over time, this can lead to weight loss
